Save today on your VTAMA cream prescription. Eligible commercially insured patients may pay as little as $0.* Commercially insured patients may pay as little as $35.*
Eligibility required. This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.
See full terms and conditions. If you have any questions regarding your eligibility or benefits, call 347-532-5250 (9:00 am - 7:00 pm ET).
Chat With a Nurse
Have questions about VTAMA cream? Chat with a nurse now.
Plaque psoriasis is a chronic skin condition that causes patches of raised, inflamed, and red skin with silvery scales. In skin of color, plaques may be thicker, have more scales, and appear like darker areas of skin. It is caused by an imbalance in your immune system that disrupts the normal function of the cells in your skin.
Your dermatologist or primary care doctor can determine whether your skin condition is plaque psoriasis and what the best treatment option is for you.
VTAMA cream is a once-daily, steroid-free prescription treatment approved by the FDA for adults with mild, moderate, or severe plaque psoriasis.
VTAMA cream can be used by adults with plaque psoriasis. See what other people who have used VTAMA cream have said about their experience.
VTAMA cream is for use on the skin (topical use) only. VTAMA cream can even be used on sensitive skin areas, like your face and neck, armpits, chest/breasts, groin, and genitals. Do not use VTAMA cream in your eyes, mouth, or vagina.
Use VTAMA cream exactly as your doctor tells you to use it.
Apply a thin layer of VTAMA cream only to your psoriasis plaques one (1) time a day. Avoid applying VTAMA cream to unaffected areas of your skin.
Wash your hands after applying VTAMA cream unless you are using it to treat plaques on your hands.
If someone else applies VTAMA cream for you, they should wash their hands after application.
With VTAMA cream, you may start seeing results as early as week 4 and clearer skin in 12 weeks. Ask your doctor if VTAMA cream is right for you.
In clinical studies, up to 80% of patients who used VTAMA cream saw some level of improvement in their plaque psoriasis in 12 weeks (compared to 35% using a cream with no active ingredient).
Learn more about the results you could achieve with VTAMA cream.
The most common side effects of VTAMA cream observed in clinical studies were folliculitis (red raised bumps around the hair pores), nasopharyngitis (pain or swelling in the nose and throat), contact dermatitis (skin rash or irritation, including itching and redness, peeling, burning, or stinging), headache, pruritus (itching), and influenza (flu).
Don’t worry! Just apply as soon as you remember to. Do not double the dose or use more than once daily. Continue treatment the next day and use VTAMA cream as your doctor instructed.
If you are having trouble keeping track of when to apply your VTAMA cream, consider setting a reminder to help.
Yes. VTAMA cream is a prescription medication. Talk to your doctor about whether VTAMA cream is right for you.
MyVTAMA™ is the patient support program from Dermavant. It was created to give you support and assistance along your plaque psoriasis treatment journey.
Dermavant is committed to making VTAMA cream accessible and affordable to commercially insured patients* with plaque psoriasis. With the MyVTAMA™ Savings Card, eligible commercially insured patients may pay as little as $0. Commercially insured patients may pay as little as $35.
If you have any questions regarding your eligibility or benefits, call 347-532-5250 (9:00 AM – 7:00 PM ET).
*Eligibility required. This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.
VTAMA cream should be stored at room temperature, between 68 °F to 77 °F (20 °C to 25 °C).
It should not be frozen or exposed to excessive heat. Keep VTAMA cream and all medicines out of the reach of children.
Sign up today to get the latest around plaque psoriasis, VTAMA (tapinarof) cream, 1%, and other helpful tips and information.
*Required field
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
 Strictly Necessary Cookies
|
Always active |
|
Performance Cookies
|
|
|
Targeting Cookies
|
Make sure to sign up for more education on plaque psoriasis and VTAMA cream before you leave the site.
Thank you for signing up. You’ll be hearing from us soon.
Have more questions? Chat live with a nurse.
No thanks, take me to the VTAMA cream website
for adults with plaque psoriasis
No thanks, take me to the VTAMA
cream website for adults with plaque psoriasis
IMPORTANT SAFETY INFORMATION
Indications: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for:
Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: red raised bumps around the hair pores (folliculitis), pain or swelling in the nose and throat (nasopharyngitis), skin rash or irritation, including itching and redness, peeling, burning, or stinging (contact dermatitis), headache, itching (pruritus), and flu (influenza).
Adverse Events: In atopic dermatitis, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
